Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Improving Outcomes After Valvular Correction
NCT00862043Phase 4Completed
- Sponsor
- Gregorio Marañón University General Hospital
- Start
- Apr 2009
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sildenafil in pulmonary hypertension (PH), sponsored by Gregorio Marañón University General Hospital. Primary endpoint: Clinical Composite Outcome at 6 months. Started Apr 2009; status: completed.
02
Drugs
sildenafil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00862043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00862043.